Cost Considerations for Systemic Therapy for Patients With Advanced Genitourinary Malignancies

Cancer - United States
doi 10.1002/cncr.31355
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Systemic Therapy for Advanced Kidney Cancer

Practical oncology
2019English

Cost Effectiveness of Regorafenib as Second-Line Therapy for Patients With Advanced Hepatocellular Carcinoma

Cancer
Cancer ResearchOncology
2017English

Considerations for Statin Therapy in Patients With COVID-19

Pharmacotherapy
Pharmacology
2020English

Immunotherapy in Genitourinary Malignancies

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2017English

Carbon Ion Therapy for Advanced Sinonasal Malignancies: Feasibility and Acute Toxicity

Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2011English

Update on Systemic Therapy for Advanced Soft Tissue Sarcoma

Current Oncology
Oncology
2020English

Peripheral CD8+ T Cell Proliferation Is Prognostic for Patients With Advanced Thoracic Malignancies

Cancer Immunology, Immunotherapy
Cancer ResearchMedicineOncologyAllergyImmunology
2012English

Pcn175 - Brentuximab Vedotin Compared With Standard Therapy for Patients With Advanced-Stage Hodgkin’s Lymphoma: A Cost-Effectiveness Analysis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Vaccine and Cancer Therapy for Genitourinary Tumors

2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy